Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kiniksa Pharmaceuticals Ltd (KNSA)

Kiniksa Pharmaceuticals Ltd (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiniksa Pharmaceuticals Ltd CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 BMU

www.kiniksa.com P: 808-451-3453

Description:

Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,207,163
Enterprise Value, $K 1,099,213
Shares Outstanding, K 70,615
Annual Sales, $ 270,260 K
Annual Net Income, $ 14,080 K
Last Quarter Sales, $ 83,400 K
Last Quarter Net Income, $ 25,240 K
EBIT, $ -25,200 K
EBITDA, $ -22,860 K
60-Month Beta 0.27
% of Insider Shareholders 54.23%
% of Institutional Shareholders 53.95%
Float, K 32,320
% Float 45.77%
Short Volume Ratio 0.67

Growth:

1-Year Return 51.63%
3-Year Return 7.41%
5-Year Return 14.06%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 02/28/24
Latest Earnings Date 04/23/24 [BMO]
Earnings Per Share ttm -0.36
EPS Growth vs. Prev Qtr 120.00%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KNSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -6.12%
Return-on-Assets % -5.20%
Profit Margin % 5.21%
Debt/Equity 0.00
Price/Sales 4.42
Price/Cash Flow N/A
Price/Book 2.71
Book Value/Share 6.23
Interest Coverage -0.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar